Reactivos e instrumentos para inmunología, biología celular y biología molecular.
 
> IgG2 Fd (HRP)

IgG2 Fd (HRP)

Imprimir Imprimir
Por favor conéctese

Referencia I1904-80F1-1ml

embalaje : 1ml

Marca : US Biological


I1904-80F1 IgG2 Fd (HRP)

Clone Type
Monoclonal
Host
mouse
Source
human
Swiss Prot
P01859
Isotype
IgG1,k
Grade
Purified
Applications
E IHC WB
Crossreactivity
Hu
Shipping Temp
Blue Ice
Storage Temp
-20°C

Applications:
Suitable for use in ELISA, Western Blot and Immunohistochemistry. Other applications have not been tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Store product at 4°C if to be used immediately within two weeks. For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20°C. Aliquots are stable at -20°C for 12 months after receipt. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Note: Sodium azide is a potent inhibitor of peroxidase and should not be added to HRP conjugates.
For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Applications
Product Type: Mab|Isotype: IgG1,k|Clone No: 3H2343 (HP6014)|Host: mouse|Source: human|Concentration: As Reported |Form: Supplied as a liquid in PBS, pH 7.4, 50% glycerol. Labeled with horseradish peroxidase (HRP) |Purity: Purified|Immunogen: Human IgG2 myeloma protein|Specificity: Recognizes an epitope in the Fab region of Human IgG2.||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Immunogen
Human IgG2 myeloma protein
Form
Supplied as a liquid in PBS, pH 7.4, 50% glycerol. Labeled with horseradish peroxidase (HRP)
Purity
Purified
Specificity
Recognizes an epitope in the Fab region of Human IgG2.
References
1. Jefferies, R., et al., (1985). Evaluation of Monoclonal Antibodies having specificity for Human IgG sub-classes. Results of an IUIS/WHO collaborative study. Immunology Letters 10: 223-252. 2. Jefferies, R., et al., (1990). Selective IgG subclass deficiency: quantification and clinical relevance. Clin. Exp. Immunol. 81: 357-367.